Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

3.94
Delayed Data
As of 3:59pm ET
 -0.14 / -3.43%
Today’s Change
2.78
Today|||52-Week Range
7.81
+12.25%
Year-to-Date
No recent news for Galmed Pharmaceuticals Ltd.

Today’s Trading

Previous close4.08
Today’s open4.08
Day’s range3.91 - 4.08
Volume39,150
Average volume (3 months)95,772
Market cap$49.6M
Dividend yield--
Data as of 3:59pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)-9.09%
Earnings growth (this year)-44.58%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.10

Competitors

 Today’s
change
Today’s
% change
MTEXMannatech Inc-0.20-1.06%
CAPRCapricor Therapeutic...-0.01-0.42%
AVEOAveo Pharmaceuticals...0.000.00%
AVIRAviragen Therapeutic...+0.10+8.06%
Data as of 3:59pm ET, 01/24/2017

Financials

Next reporting dateApril 4, 2017
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$0.00
Annual profit (last year)-$10.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO &
Class II Director
Allen Baharaff
Chief Financial Officer
Josh Blacher
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts


Search for Jobs